CLINICAL_TRIALS
trial_result
· 2020-04-09
Clinical Trial Update: Flavopiridol in Treating Patients With Previously Untreated or Relapsed Mantle Cell Lymphoma [Phase 2]
Summary
Phase 2 trial evaluating flavopiridol in patients with previously untreated or relapsed mantle cell lymphoma has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: NCIC Clinical Trials Group | Conditions: Lymphoma | Phase 2 | Status: COMPLETED